BioConnect
PrivateLast Round
Grant
Jul 17, 2024
Total Funding Raised
$361,500
Company Overview
BioConnect is a healthtech company that provides services like vision-based biometric information measurement, chronic disease management, and lab information management solutions.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Telemedicine, Document Management, Computer Vision, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioConnect Comparables
Compare BioConnect with similar companies based on industry and business-model similarity.
BioConnect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 17, 2024 | ||||
| Seed | Jan 19, 2021 |
BioConnect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ActnerLab | Grant, Seed |
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 71% MoM, reaching 8.7K.
- Jan 22, 2026
Monthly visitors grew 702% MoM, reaching 5.1K.
BioConnect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioConnect's valuation, stock price, and market status.
Is BioConnect a public or private company?
BioConnect is a private company.
What is the current stock price of BioConnect?
BioConnect is a private company, so its shares have no public market price. Caplight tracks BioConnect's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioConnect worth (valuation)?
Valuation information for BioConnect is not publicly available.
Can I buy BioConnect stock?
BioConnect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioConnect's last funding round?
BioConnect's most recent funding round was Grant on July 17, 2024.
Who are the main investors in BioConnect?
Key investors in BioConnect include ActnerLab.
Will BioConnect IPO soon?
No public IPO plans have been announced for BioConnect.
How can I track BioConnect secondary market activity?
Caplight tracks bids, offers, and trades in BioConnect's shares on secondary markets.